Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

p19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferation.

Bai F, Chan HL, Smith MD, Kiyokawa H, Pei XH.

Mol Cell Biol. 2014 Jun;34(12):2121-34. doi: 10.1128/MCB.01363-13.

2.

p19Ink4d and p18Ink4c cyclin-dependent kinase inhibitors in the male reproductive axis.

Buchold GM, Magyar PL, Arumugam R, Lee MM, O'Brien DA.

Mol Reprod Dev. 2007 Aug;74(8):997-1007.

PMID:
17342741
3.

Genetic evidence for functional dependency of p18Ink4c on Cdk4.

Pei XH, Bai F, Tsutsui T, Kiyokawa H, Xiong Y.

Mol Cell Biol. 2004 Aug;24(15):6653-64.

4.

Control of spermatogenesis in mice by the cyclin D-dependent kinase inhibitors p18(Ink4c) and p19(Ink4d).

Zindy F, den Besten W, Chen B, Rehg JE, Latres E, Barbacid M, Pollard JW, Sherr CJ, Cohen PE, Roussel MF.

Mol Cell Biol. 2001 May;21(9):3244-55.

5.

Mice lacking cyclin-dependent kinase inhibitor p19Ink4d show strain-specific effects on male reproduction.

Buchold GM, Magyar PL, O'Brien DA.

Mol Reprod Dev. 2007 Aug;74(8):1008-20.

PMID:
17393423
6.

Novel expression of cyclin-dependent kinase inhibitors in human B-cell precursors.

Fink JR, LeBien TW.

Exp Hematol. 2001 Apr;29(4):490-8.

PMID:
11301189
7.
8.

Cdk4 is indispensable for postnatal proliferation of the anterior pituitary.

Jirawatnotai S, Aziyu A, Osmundson EC, Moons DS, Zou X, Kineman RD, Kiyokawa H.

J Biol Chem. 2004 Dec 3;279(49):51100-6.

PMID:
15456744
10.

Cyclin-dependent kinase inhibitor p27(Kip1) is required for mouse mammary gland morphogenesis and function.

Muraoka RS, Lenferink AE, Simpson J, Brantley DM, Roebuck LR, Yakes FM, Arteaga CL.

J Cell Biol. 2001 May 28;153(5):917-32.

11.

MEN1 tumorigenesis in the pituitary and pancreatic islet requires Cdk4 but not Cdk2.

Gillam MP, Nimbalkar D, Sun L, Christov K, Ray D, Kaldis P, Liu X, Kiyokawa H.

Oncogene. 2015 Feb 12;34(7):932-8. doi: 10.1038/onc.2014.3.

12.

Senescence mediates pituitary hypoplasia and restrains pituitary tumor growth.

Chesnokova V, Zonis S, Rubinek T, Yu R, Ben-Shlomo A, Kovacs K, Wawrowsky K, Melmed S.

Cancer Res. 2007 Nov 1;67(21):10564-72.

13.

Lineage specific composition of cyclin D-CDK4/CDK6-p27 complexes reveals distinct functions of CDK4, CDK6 and individual D-type cyclins in differentiating cells of embryonic origin.

Bryja V, Pacherník J, Vondrácek J, Soucek K, Cajánek L, Horvath V, Holubcová Z, Dvorák P, Hampl A.

Cell Prolif. 2008 Dec;41(6):875-93. doi: 10.1111/j.1365-2184.2008.00556.x.

14.

A new pathway for mitogen-dependent cdk2 regulation uncovered in p27(Kip1)-deficient cells.

Coats S, Whyte P, Fero ML, Lacy S, Chung G, Randel E, Firpo E, Roberts JM.

Curr Biol. 1999 Feb 25;9(4):163-73.

15.

Genetic evidence for the interactions of cyclin D1 and p27(Kip1) in mice.

Tong W, Pollard JW.

Mol Cell Biol. 2001 Feb;21(4):1319-28.

16.

RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors.

Zhang S, Tang Q, Xu F, Xue Y, Zhen Z, Deng Y, Liu M, Chen J, Liu S, Qiu M, Liao Z, Li Z, Luo D, Shi F, Zheng Y, Bi F.

Mol Cancer Res. 2009 Apr;7(4):570-80. doi: 10.1158/1541-7786.MCR-08-0248.

17.

Combined loss of INK4a and caveolin-1 synergistically enhances cell proliferation and oncogene-induced tumorigenesis: role of INK4a/CAV-1 in mammary epithelial cell hyperplasia.

Williams TM, Lee H, Cheung MW, Cohen AW, Razani B, Iyengar P, Scherer PE, Pestell RG, Lisanti MP.

J Biol Chem. 2004 Jun 4;279(23):24745-56.

PMID:
15044451
18.

A mutant allele of BARA/LIN-9 rescues the cdk4-/- phenotype by releasing the repression on E2F-regulated genes.

Sandoval R, Xue J, Tian X, Barrett K, Pilkinton M, Ucker DS, Raychaudhuri P, Kineman RD, Luque RM, Baida G, Zou X, Valli VE, Cook JL, Kiyokawa H, Colamonici OR.

Exp Cell Res. 2006 Aug 1;312(13):2465-75.

PMID:
16730350
19.

Attenuation of the retinoblastoma pathway in pancreatic neuroendocrine tumors due to increased cdk4/cdk6.

Tang LH, Contractor T, Clausen R, Klimstra DS, Du YC, Allen PJ, Brennan MF, Levine AJ, Harris CR.

Clin Cancer Res. 2012 Sep 1;18(17):4612-20. doi: 10.1158/1078-0432.CCR-11-3264.

20.

Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity.

Tsutsui T, Hesabi B, Moons DS, Pandolfi PP, Hansel KS, Koff A, Kiyokawa H.

Mol Cell Biol. 1999 Oct;19(10):7011-9.

Items per page

Supplemental Content

Support Center